Parexel International (ma) Corporation
Location
Massachusetts
Founded
1983-02-28
Website
Risk Signals
451 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Commercial Physical and Biological Research), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Parexel International (ma) Corporation
Live alerts from global media, monitored by Business Radar
2024-09-18 (market.us)
Medical Writing Market Boom: Predicted $9.4 Billion Value by 2032
Medical Writing Market Size is expected to reach USD 9.4 Billion by 2032 from USD 3.6 Billion in 2022, growing at a CAGR of 10.4%.
Read more
2024-09-04 (businessfacilities.com)
Expansion And HQ Relocation Bring Jobs To North Carolina
Reliance Packaging LLC invests $2.7M to expand operations in Moore County, creating 32 jobs; Parexel relocates headquarters to a 61,076SF office in Raleigh, North Carolina.
Read more
2023-06-06 (pharmtech.com)
Drug Solutions Podcast: Examining the State of Biopharma Investment
In this episode, Siegfried Schmitt, vice president, Technical at Parexel, discusses the state of biopharma investment in 2023.
Read more
2021-12-13 (informa.com)
Parexel Exec Says Non-COVID-19 Drug Discovery Back With A Bang
Clinical trial initiations in cell and gene therapies and immuno-oncology are seeing a spike as the COVID-19 experience has shown the benefits of beginning research early, Parexel’s executive vice president says.
Read more
2021-07-02 (wsj.com)
EQT and Goldman to Buy Parexel
The firms agreed to acquire the contract-research organization for $8.5 billion, including debt.
Read more
(market.us)
Preclinical CRO Market Will Hit USD 10.5 Billion by 2032
Preclinical CRO Market size is expected to reach USD 10.5 Billion by 2032 from USD 5.2 Billion in 2022, at a CAGR of 7.5% (from 2023 to 2032)
Read more